FRANKLIN, Mass., June 12 /PRNewswire-FirstCall/ -- Sontra Medical
Corporation (Nasdaq: SONT) announced today that its Chief Financial
Officer, Sean Moran, has resigned his position with the Company to pursue a
new career opportunity.
The Company has appointed Mr. Harry G. Mitchell, C.P.A. to serve as
Interim Chief Financial Officer. Mr. Mitchell has been C.E.O. and C.F.O.
for several medical device and technology companies. Since 2004, Mr.
Mitchell has served as President and Chief Executive Officer of MedTech
Advances, Inc. and has provided financial and other consulting services to
several other corporations. From 1999 to 2004, Mr. Mitchell was Chief
Financial Officer of Boston Medical Technologies, Inc. To further
strengthen the Company's finance staff, Karen Cowgill has been promoted to
Controller from Director of Administration.
The Company has retained an executive recruiter and has commenced a
search for a permanent Chief Financial Officer.
"We thank Sean for his dedication and financial leadership during his
time at Sontra and wish him well," stated Thomas W. Davison, PhD, President
and Chief Executive Officer. Mr. Moran will remain with the Company until
June 23rd to ensure an effective transition of responsibilities to Mr.
Mitchell and Ms. Cowgill.
About Sontra Medical Corporation (http://www.sontra.com)
Sontra Medical Corporation is a technology leader in transdermal
science. Sontra's SonoPrep ultrasound-mediated skin permeation technology
combined with technical competencies in transdermal drug formulation,
delivery systems and biosensors is creating a new paradigm in transdermal
drug delivery and diagnosis. The SonoPrep technology is being developed for
several billion dollar market opportunities, including continuous glucose
monitoring and the transdermal delivery of large molecule drugs and
vaccines. Sontra is currently marketing the SonoPrep device and procedure
tray for use with topical lidocaine to achieve rapid (within five minutes)
skin anesthesia.
Investor Relations Contact:
Karen Cowgill, Controller, Sontra Medical 508-553-0322
Harry G. Mitchell, Interim CFO, Sontra Medical 508-530-0311
This press release contains forward-looking statement. Statements that
are not historical facts, including statements about our beliefs and
expectations, are forward-looking statements and include statements
regarding our planned strategic initiatives and our ability to maintain a
listing on Nasdaq. Such statements are based on our current expectations
and are subject to a number of factors and uncertainties, which could cause
actual results to differ materially from those described in the
forward-looking statements. Such factors and uncertainties include, but are
not limited to, that the Company will not be successful in its request for
continued listing, and risks related to our planned strategic initiatives,
including that such initiatives may not occur as planned or that they do
not result in continued listing. Forward- looking statements speak only as
of the date they are made, and we undertake no duty or obligation to update
any forward-looking statements in light of new information or future
events, unless required by law. For detailed information about factors that
could cause actual results to differ materially from those described in the
forward-looking statements, please refer to Sontra's filings with the
Securities and Exchange Commission, including Sontra's most recent
Quarterly Report on Form 10-QSB.
SOURCE Sontra Medical Corporation
 back to top
Related links:
http://www.sontra.com
CONTACT:
Karen Cowgill, Controller, +1-508-553-0322,
or Harry G. Mitchell, Interim CFO, +1-508-530-0311, both of
Sontra Medical
|
